Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aardvark Therapeutics, Inc. | 70,549 | reported | 09 Feb 2026 | tx 7+235,827−129,881 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Feb 2026 | GRANT_AWARD | Aardvark Therapeutics, Inc. | 70,549 | 0.00 USD | deriv |
| 11 Dec 2025 | PURCHASE | Aardvark Therapeutics, Inc. | 3,000 | 14.40 USD | |
| 09 Sept 2025 | PURCHASE | Aardvark Therapeutics, Inc. | 6,000 | 8.07 USD | |
| 11 Jun 2025 | GRANT_AWARD | Aardvark Therapeutics, Inc. | 209,826 | 0.00 USD | deriv |
| 14 Feb 2025 | PURCHASE | Aardvark Therapeutics, Inc. | 10,000 | 16.00 USD | |
| 14 Feb 2025 | CONVERSION | Aardvark Therapeutics, Inc. | 7,001 | — | |
| 14 Feb 2025 | CONVERSION | Aardvark Therapeutics, Inc. | 59,332 | 0.00 USD | deriv |